Internal Medicine, Pulmonary Disease · Oklahoma City, OK
NPI
1255426417
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3400 NW Expressway Ste 700
Oklahoma City, OK, 73112
Phone (405) 951-8191
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
818 services
Medicare patients, 2024
94
Average age 66
Drug cost, 2024
$174K
538 prescriptions
Company payments, 2025
$229
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark W Rolfe was code 99233 (hospital e&m - subsequent), 199 times for 24 patients. In total Mark W Rolfe billed 818 services in 33 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 199 | 24 | $87.97 | $18K |
| 99232 Hospital E&M - Subsequent | Facility | 153 | 31 | $59.40 | $9,088 |
| 94010 Pulmonary Function Testing | Facility | 94 | 65 | $6.12 | $575 |
| 99214 Office E&M - Established | Facility | 63 | 46 | $72.22 | $4,550 |
| 31624 Bronchoscopy | Facility | 46 | 22 | $15.85 | $729 |
| 31628 Bronchoscopy | Facility | 38 | 17 | $120.04 | $4,562 |
| 99231 Hospital E&M - Subsequent | Facility | 36 | 13 | $37.29 | $1,342 |
| 99238 Hospital Discharge Management | Facility | 34 | 25 | $59.20 | $2,013 |
| 99222 Hospital E&M - Initial | Facility | 17 | 15 | $98.24 | $1,670 |
| 99223 Hospital E&M - Initial | Facility | 12 | 11 | $130.53 | $1,566 |
By year: 2022 $16K for 182 services; 2024 $56K for 818 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark W Rolfe prescribed most often to Medicare patients was Pantoprazole Sodium, with 51 prescriptions and refills. In total Mark W Rolfe wrote 538 Medicare prescriptions that cost $174K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 51 | 79 | 13 | $245 |
| Prednisone Generic | 48 | 80 | 20 | $337 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 33 | 47 | 13 | $76.82 |
| Azithromycin Generic | 30 | 36 | Under 11 | $633 |
| Valganciclovir Hcl Generic | 28 | 28 | Under 11 | $7,726 |
| Carvedilol Generic | 21 | 27 | Under 11 | $69.56 |
| Amphotericin B Liposome Generic | 15 | 15 | Under 11 | $19K |
| Tacrolimus Generic | 13 | 21 | Under 11 | $2,568 |
| Amlodipine Besylate Generic | 12 | 24 | Under 11 | $53.63 |
| Metoclopramide Hcl Generic | 12 | 13 | Under 11 | $40.19 |
| Fluconazole Generic | 11 | 15 | Under 11 | $136 |
| Levothyroxine Sodium Generic | 11 | 23 | Under 11 | $104 |
Brand drugs: - claims; generic drugs: 474 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark W Rolfe $229 ($229 in general payments such as food, travel and fees) from 3 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $157.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $157 |
| Paratek Pharmaceuticals, Inc. | 2 | $45.13 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $26.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.